BNP: Not just for heart failure

Heart

Volumn 94, Issue 1, 2008, Pages 6-7

  Nicholls, M G ^a   Frampton, C M ^a   Yandle, T G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; DISEASE MARKER; DISEASE PREDISPOSITION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 37749033431     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.119925     Document Type: Editorial

References (17)

1. Khan SQ, Quinn P, Davies JE, et al. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death following acute myocardial infarction. Heart 2008;94:40-3.
2. Gill D, Seidler T, Troughton RW, et al. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction. Clin Sci 2004;106:135-9.
3. Baxter GF. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol 2004;99:90-3.
4. Nakanishi M, Saito Y, Kishimoto I, et al. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice. Hypertension 2005;46:441-7.
5. Ndrepepa G, Braun S, Mehilli J, et al. N-terminal probrain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy or reperfusion, and prognosis. Am J Cardiol 2006;97:1151-6.
6. Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 2004;6:327-33.
7. Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005;294:2866-71.
8. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
9. Björklund E, Jernberg T, Johanson P, et al. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2006;92:735-40.
10. Bazzino O, Fuselli JJ, Botto F, et al. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2004;25:859-66.
11. Squire IB, Ørn S, Ng LL, et al. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. J Card Fail 2005;11:492-7.
12. Lindahl B, Lindbäck J, Jernberg T, et al. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2005;45:533-41.
13. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
14. Ala-Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:1576-88.
15. Yandle T, Fisher S, Espiner E, et al. Validating aminoterminal BNP assays: a word of caution. Lancet 1999;353:1068- 9.
16. Motwani JG, McAlpine H, Kennedy N, et al. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
17. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry laboratory medicine guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007;115:e356-75.